ProfileGDS4459 / ENSG00000162852
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 83% 85% 85% 82% 83% 85% 79% 84% 83% 82% 83% 79% 86% 75% 85% 82% 85% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 16.283
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 26.4485
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 36.6985
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 46.0682
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 56.4583
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 66.5885
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 76.0779
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 86.6484
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 96.5783
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 106.3682
GSM623474group B, liver allograft wedge biopsie placebo treatment 16.4483
GSM623475group B, liver allograft wedge biopsie placebo treatment 26.1479
GSM623476group B, liver allograft wedge biopsie placebo treatment 36.7986
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.4675
GSM623478group B, liver allograft wedge biopsie placebo treatment 56.7985
GSM623479group B, liver allograft wedge biopsie placebo treatment 66.0882
GSM623480group B, liver allograft wedge biopsie placebo treatment 76.5885